Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

Xianhe Bai, Francesca Cerimele, Masuko Ushio-Fukai, Muhammad Waqas, Paul M. Campbell, Baskaran Govindarajan, Channing J. Der, Traci Battle, David A. Frank, Keqiang Ye, Emma Murad, Wolfgang Dubiel, Gerald Soff, Jack L. Arbiser

Research output: Contribution to journalArticle

281 Citations (Scopus)

Abstract

Natural products comprise a major source of small molecular weight angiogenesis inhibitors. We have used the transformed endothelial cell line SVR as an effective screen of natural product extracts to isolate anti-angiogenesis and anti-tumor compounds. Aqueous extracts of Magnolia grandiflora exhibit potent activity in our SVR proliferation assays. We found that the small molecular weight compound honokiol is the active principle of magnolia extract. Honokiol exhibited potent anti-proliferative activity against SVR cells in vitro. In addition, honokiol demonstrated preferential inhibition of primary human endothelial cells compared with fibroblasts and this inhibition was antagonized by antibodies against TNFα-related apoptosis-inducing ligand. In vivo, honokiol was highly effective against angiosarcoma in nude mice. Our preclinical data suggests that honokiol is a systemically available and non-toxic inhibitor of angiogenesis and should be further evaluated as a potential chemotherapeutic agent.

Original languageEnglish (US)
Pages (from-to)35501-35507
Number of pages7
JournalJournal of Biological Chemistry
Volume278
Issue number37
DOIs
StatePublished - Sep 12 2003

Fingerprint

Biological Products
Tumors
Molecular Weight
Molecular weight
Magnolia
Growth
Angiogenesis Inhibitors
Endothelial cells
Neoplasms
Endothelial Cells
TNF-Related Apoptosis-Inducing Ligand
Transformed Cell Line
Hemangiosarcoma
Fibroblasts
Nude Mice
Assays
In Vitro Techniques
honokiol
Antibodies

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. / Bai, Xianhe; Cerimele, Francesca; Ushio-Fukai, Masuko; Waqas, Muhammad; Campbell, Paul M.; Govindarajan, Baskaran; Der, Channing J.; Battle, Traci; Frank, David A.; Ye, Keqiang; Murad, Emma; Dubiel, Wolfgang; Soff, Gerald; Arbiser, Jack L.

In: Journal of Biological Chemistry, Vol. 278, No. 37, 12.09.2003, p. 35501-35507.

Research output: Contribution to journalArticle

Bai, X, Cerimele, F, Ushio-Fukai, M, Waqas, M, Campbell, PM, Govindarajan, B, Der, CJ, Battle, T, Frank, DA, Ye, K, Murad, E, Dubiel, W, Soff, G & Arbiser, JL 2003, 'Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo', Journal of Biological Chemistry, vol. 278, no. 37, pp. 35501-35507. https://doi.org/10.1074/jbc.M302967200
Bai, Xianhe ; Cerimele, Francesca ; Ushio-Fukai, Masuko ; Waqas, Muhammad ; Campbell, Paul M. ; Govindarajan, Baskaran ; Der, Channing J. ; Battle, Traci ; Frank, David A. ; Ye, Keqiang ; Murad, Emma ; Dubiel, Wolfgang ; Soff, Gerald ; Arbiser, Jack L. / Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. In: Journal of Biological Chemistry. 2003 ; Vol. 278, No. 37. pp. 35501-35507.
@article{bc74c28a75d140e288165a82d57bfbd0,
title = "Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo",
abstract = "Natural products comprise a major source of small molecular weight angiogenesis inhibitors. We have used the transformed endothelial cell line SVR as an effective screen of natural product extracts to isolate anti-angiogenesis and anti-tumor compounds. Aqueous extracts of Magnolia grandiflora exhibit potent activity in our SVR proliferation assays. We found that the small molecular weight compound honokiol is the active principle of magnolia extract. Honokiol exhibited potent anti-proliferative activity against SVR cells in vitro. In addition, honokiol demonstrated preferential inhibition of primary human endothelial cells compared with fibroblasts and this inhibition was antagonized by antibodies against TNFα-related apoptosis-inducing ligand. In vivo, honokiol was highly effective against angiosarcoma in nude mice. Our preclinical data suggests that honokiol is a systemically available and non-toxic inhibitor of angiogenesis and should be further evaluated as a potential chemotherapeutic agent.",
author = "Xianhe Bai and Francesca Cerimele and Masuko Ushio-Fukai and Muhammad Waqas and Campbell, {Paul M.} and Baskaran Govindarajan and Der, {Channing J.} and Traci Battle and Frank, {David A.} and Keqiang Ye and Emma Murad and Wolfgang Dubiel and Gerald Soff and Arbiser, {Jack L.}",
year = "2003",
month = "9",
day = "12",
doi = "10.1074/jbc.M302967200",
language = "English (US)",
volume = "278",
pages = "35501--35507",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "37",

}

TY - JOUR

T1 - Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

AU - Bai, Xianhe

AU - Cerimele, Francesca

AU - Ushio-Fukai, Masuko

AU - Waqas, Muhammad

AU - Campbell, Paul M.

AU - Govindarajan, Baskaran

AU - Der, Channing J.

AU - Battle, Traci

AU - Frank, David A.

AU - Ye, Keqiang

AU - Murad, Emma

AU - Dubiel, Wolfgang

AU - Soff, Gerald

AU - Arbiser, Jack L.

PY - 2003/9/12

Y1 - 2003/9/12

N2 - Natural products comprise a major source of small molecular weight angiogenesis inhibitors. We have used the transformed endothelial cell line SVR as an effective screen of natural product extracts to isolate anti-angiogenesis and anti-tumor compounds. Aqueous extracts of Magnolia grandiflora exhibit potent activity in our SVR proliferation assays. We found that the small molecular weight compound honokiol is the active principle of magnolia extract. Honokiol exhibited potent anti-proliferative activity against SVR cells in vitro. In addition, honokiol demonstrated preferential inhibition of primary human endothelial cells compared with fibroblasts and this inhibition was antagonized by antibodies against TNFα-related apoptosis-inducing ligand. In vivo, honokiol was highly effective against angiosarcoma in nude mice. Our preclinical data suggests that honokiol is a systemically available and non-toxic inhibitor of angiogenesis and should be further evaluated as a potential chemotherapeutic agent.

AB - Natural products comprise a major source of small molecular weight angiogenesis inhibitors. We have used the transformed endothelial cell line SVR as an effective screen of natural product extracts to isolate anti-angiogenesis and anti-tumor compounds. Aqueous extracts of Magnolia grandiflora exhibit potent activity in our SVR proliferation assays. We found that the small molecular weight compound honokiol is the active principle of magnolia extract. Honokiol exhibited potent anti-proliferative activity against SVR cells in vitro. In addition, honokiol demonstrated preferential inhibition of primary human endothelial cells compared with fibroblasts and this inhibition was antagonized by antibodies against TNFα-related apoptosis-inducing ligand. In vivo, honokiol was highly effective against angiosarcoma in nude mice. Our preclinical data suggests that honokiol is a systemically available and non-toxic inhibitor of angiogenesis and should be further evaluated as a potential chemotherapeutic agent.

UR - http://www.scopus.com/inward/record.url?scp=0041816087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041816087&partnerID=8YFLogxK

U2 - 10.1074/jbc.M302967200

DO - 10.1074/jbc.M302967200

M3 - Article

C2 - 12816951

AN - SCOPUS:0041816087

VL - 278

SP - 35501

EP - 35507

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 37

ER -